Back

Clinical and angiographic results after scoring-balloon angioplasty and sirolimus-eluting balloon angioplasty for the treatment of diffuse, small vessel coronary artery disease (SCA-DEB Study)

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Optimising revascularisation in calcified lesions Primary Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dobrin Vassilev

Medica Kor, Ruse (Bulgaria)

5 More presentations in this session

Presentation thumbnail
Prediction of percutaneous coronary intervention success in moderate-to-severe coronary artery calcification patients based on coronary angiography
Doctor Z. Ye (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Intravascular lithotripsy for preparation of coronary lesions treated with drug coated balloons: Insights from a prospective registry.
Doctor D. Paugsch (Luzern, CH)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes after rotational vs. orbital atherectomy for calcified lesions: insights from the DIRO trial
Doctor S. Kawanami (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Intravascular Lithotripsy in the modification of calcified nodules: A Meta-Analysis
Doctor M. Sagris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Impact of debulking devices in percutaneous coronary intervention for acute myocardial infarction with severely calcified lesions: a retrospective analysis
Doctor T. Kodama (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising revascularisation in calcified lesions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Late-breaking science on acute coronary syndromes
thumbnail
Congress Session
Innovations in coronary intervention: lithotripsy, atherectomy, and drug-coated balloons
thumbnail
Congress Presentation
SELUTION DeNovo trial: evidence and impact on practice ​

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources